A diet based on multiple functional concepts improves cardiometabolic risk parameters in healthy subjects

Nutrition and Metabolism

Volumn 9, Issue , 2012, Pages

  Tovar, Juscelino ^a   Nilsson, Anne ^a   Johansson, Maria ^a   Ekesbo, Rickard ^b   Åberg, Ann Margreth ^b   Johansson, Ulla ^c   Björck, Inger ^a  

^a LUND UNIVERSITY   (Sweden)

^b Primary Health Care Centre   (Sweden)

^c Idun Mat Och Näringskonsult   (Sweden)

Author keywords

Cardiometabolic disease; crossover design; dietary prevention; functional foods; metabolic syndrome; randomized controlled trial

Indexed keywords

APOLIPOPROTEIN A1; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; PROBIOTIC AGENT; STANOZOLOL; TRIACYLGLYCEROL;

ADULT; ALMOND; ANTIOXIDANT ACTIVITY; ARTICLE; BARLEY; BODY WEIGHT; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET; DIETARY FIBER; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN SENSITIVITY; LACTOBACILLUS PLANTARUM; MALE; NUTRITIONAL ASSESSMENT; OBESITY; RANDOMIZED CONTROLLED TRIAL; SEED KERNEL; SOYBEAN; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

GLYCINE MAX; HORDEUM; LACTOBACILLUS PLANTARUM;

EID: 84859139090     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-9-29     Document Type: Article

References (65)

1. WHO, The Global Burden of Disease: 2004 Update Gèneve, Switzerland: World Health Organization 2008
2. Nutritional strategies in the prevention and treatment of metabolic syndrome. Feldeisen SE, Tucker KL, Appl Physiol Nutr Metab 2007 32 42 60
3. Defining and setting national goals for cardiovascular health promotion and disease reduction: The American Heart Association's strategic impact goal through 2020 and beyond. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow C, Ho M, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD, Circulation 2010 121 586 613 10.1161/CIRCULATIONAHA.109.192703 20089546
4. A dietary portfolio approach to cholesterol reduction: Combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. Jenkins DJA, Kendall CWC, Faulkner D, Vidgen E, Trautwein EA, Parker TL, Marchie A, Koumbridis G, Lapsley KG, Josse R, Leiter LA, Connelly PW, Metabolism 2002 51 1596 1604 10.1053/meta.2002.35578 12489074
5. Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Jenkins DJA, Kendall CWC, Marchie A, Faulkner DA, Josse AR, Wong JM, de Souza R, Emam A, Parker TL, Vidgen E, Trautwein EA, Lapsley KG, Josse RG, Leiter LA, Singer W, Connelly PW, Am J Clin Nutr 2005 81 380 387 15699225
6. Adding monounsaturated fatty acids to a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. Jenkins DJ, Chiavaroli L, Wong JM, Kendall C, Lewis GF, Vidgen E, Connelly PW, Leiter LA, Josse RG, Lamarche B, Can Med Assoc J 2010 182 1961 1967 10.1503/cmaj.092128
7. Direct comparison of dietary portfolio vs statin on C-reactive protein. Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Josse AR, Wong JM, de Souza R, Emam A, Parker TL, Eur J Clin Nutr 2005 59 851 860 10.1038/sj.ejcn.1602152 15900306
8. Effects of a healthy Nordic diet on cardiovascular risk factors in hypercholesterolaemic subjects: a randomized controlled trial (NORDIET). Adamsson V, Reumark A, Fredriksson IB, Hammarström E, Vessby B, Johansson G, Risérus U, J Intern Med 2011 269 150 159 10.1111/j.1365-2796.2010. 02290.x 20964740
9. Dietary strategies for improving post-prandial glucose, lipids, inflammation and cardiovascular health. O'Keefe JH, Gheewala NM, O'Keefe JO, J Am Coll Cardiol 2008 51 249 255 10.1016/j.jacc.2007.10.016 18206731
10. Polyunsaturated fatty acids effect on serum triglycerides concentration in the presence of metabolic syndrome components. The Alaska-Siberia Project. Lopez-Alvarenga JC, Ebbesson SOE, Ebbesson LO, Tejero M, Vorugantia S, Comuzzie AG, Metabolism 2010 59 86 92 10.1016/j.metabol.2009.07.010 19766268
11. The developmental origins, mechanisms and implications of metabolic syndrome. Bruce KD, Hanson MA, J Nutr 2010 140 648 652 10.3945/jn.109.111179 20107145
12. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Expert Panel on Detection, and Treatment of High Blood Cholesterol in Adults, Circulation 2002 106 3143 3421 12485966
13. The effects of diet on inflammation-Emphasis on the metabolic syndrome. Giugliano D, Ceriello A, Esposito K, J Am Coll Cardiol 2006 48 677 685 10.1016/j.jacc.2006.03.052 16904534
14. Vinegar dressing and cold storage of potatoes lowers postprandial glycaemic and insulinaemic responses in healthy subjects. Leeman M, Ostman E, Bjorck I, Eur J Clin Nutr 2005 59 1266 1271 10.1038/sj.ejcn.1602238 16034360
15. Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks. Nilsson M, Holst JJ, Bjorck IME, Am J Clin Nutr 2007 85 996 1004 17413098
16. Food selection based on total antioxidant capacity can modify antioxidant intake, systemic inflammation, and liver function without altering markers of oxidative stress. Valtuena S, Pellegrini N, Franzini L, Bianchi MA, Ardig D, Del Rio D, Piatti P, Scazzina F, Zavaroni I, Brighenti F, Am J Clin Nutr 2008 87 1290 1297 18469252
17. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Calder PC, Am J Clin Nutr 2006 83 Suppl 6 1505S 1519S 16841861
18. Endotoxin- and D-galactosamine-induced liver injury improved by the administration of Lactobacillus, Bifidobacterium and blueberry. Osman N, Adawi D, Ahrne S, Jeppsson B, Molin G, Dig Liver Dis 2007 39 849 856 10.1016/j.dld.2007.06.001 17652039
19. Prebiotic potential of barley derived beta-glucan at low intake levels: A randomised, double-blinded, placebo-controlled clinical study. Mitsou EK, Panopoulou N, Turunen K, Spiliotis V, Kyriacou A, Food Res Int 2010 43 1086 1092 10.1016/j.foodres.2010.01.020
20. Effects of GI vs content of cereal fibre of the evening meal on glucose tolerance at a subsequent standardized breakfast. Nilsson A, Ostman E, Preston T, Björck I, Eur J Clin Nutr Nutr 2008 62 712 720 10.1038/sj.ejcn.1602784
21. Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. Nilsson AC, Ostman EM, Holst JJ, Björck IM, J Nutr 2008 138 732 739 18356328
22. Nordic Council of Ministers, Nutrition Recommendations 2004: integrating nutrition and physical activity Copenhagen: Nordic Council of Ministers 4 2004
23. Natural antioxidant compounds in risk factors for CVD. Kaliora AC, Dedoussis GVZ, Pharmacol Res 2007 56 99 109 10.1016/j.phrs.2007.04.018 17572098
24. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Erlund I, Koli R, Alfthan G, Marniemi J, Puukka P, Mustonen P, Mattila P, Jula A, Am J Clin Nutr 2008 87 323 331 18258621
25. From type 2 diabetes to antioxidant activity: a systematic review of the safety and efficacy of common and cassia cinnamon bark. Dugoua JJ, Seely D, Perri D, Cooley K, Forelli T, Mills E, Koren G, Can J Physiol Pharmacol 2007 85 837 847 10.1139/Y07-080 18066129
26. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides. Musa-Veloso K, Binns MA, Kocenas AC, Poon T, Elliot JA, Rice H, Oppedal-Olsen H, Lloyd H, Lemke S, Nutr Rev 2010 68 155 167 10.1111/j.1753-4887.2010.00272.x 20384846
27. Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. McKeown NM, Meigs JB, Liu S, Saltzman E, Wilson PW, Jacques PF, Diabetes Care 2004 27 538 546 10.2337/diacare.27.2.538 14747241
28. Glycemic index, glycemic load and diabetes risk: a meta-analysis. Barclay A, Petocz P, McMillan-Price J, Flood V, Prvan T, Mitchell P, Brand-Miller J, Diabetes Res Clin Pract 2008 79 Suppl 1 30 S31
29. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update. Ceriello A, Davidson J, Hanefeld M, Leiter L, Monnier L, Owens D, Tajima N, Tuomilehto J, Nutr Metab Cardiovasc Dis 2006 16 453 456 10.1016/j.numecd.2006.05.006 16934443
30. Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Padyab M, Hu FB, Willett WC, Am J Clin Nutr 2007 85 735 741 17344494
31. Effects of plant sterols and stanols beyond low-density lipoprotein cholesterol lowering. Derdemezis CS, Filippatos TD, Mikhailidis DP, J Cardiovasc Pharmacol Ther 2010 15 120 314 10.1177/1074248409357921 20200328
32. Tree nuts and the lipid profile: a review of clinical studies. Griel AE, Kris-Etherton PM, Br J Nutr 2006 96 Suppl 2 68 S78 17125536
33. Soy consumption, markers of inflammation, and endothelial function: a cross-over study in postmenopausal women with the metabolic syndrome. Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Hu FB, Willett WC, Diabetes Care 2007 30 967 973 10.2337/dc06-2126 17392557
34. Soy and cardio-metabolic abnormalities: an update. Azadbakht L, Esmaillzadeh A, J Res Med Sci 2008 13 88 96
35. Mechanisms of anti-atherosclerotic functions of soy-based diets. Nagarajan S, J Nutr Biochem 2010 21 255 260 10.1016/j.jnutbio.2009.09.002 19954957
36. Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. Basu A, Du M, Leyva MJ, Sanchez K, Betts NM, Wu M, Aston CE, Lyons TJ, J Nutr 2010 140 1582 1587 10.3945/jn.110.124701 20660279
37. Probiotics, immune function, infection and inflammation: A review of the evidence from studies conducted in humans. Lomax AR, Calder PC, Curr Pharm Des 2009 15 1428 1518 10.2174/138161209788168155 19442167
38. Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Ooi LG, Liong MT, Int J Mol Sci 2010 11 2499 2522 10.3390/ijms11062499 20640165
39. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Friedewald WT, Levy RI, Fredriksson DS, Clin Chem 1972 18 499 502 4337382
40. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, Diabetologia 1985 28 412 419 10.1007/BF00280883 3899825
41. An updated coronary risk profile -a statement for health-professionals. Anderson KM, Wilson PWF, Odell PM, Kannel WB, Circulation 1991 83 356 362 1984895
42. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women-The Reynolds Risk Score. Ridker PM, Buring JE, Rifai N, Cook NR, JAMA 2007 297 611 619 10.1001/jama.297.6.611 17299196
43. C-Reactive Protein and parental history improve global cardiovascular risk prediction: The Reynolds Risk Score for men. Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR, Circulation 2008 118 2243 2251 10.1161/CIRCULATIONAHA. 108.814251 18997194
44. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Hulthe J, Fagerberg B, Arterioscler Thromb Vasc Biol 2002 22 1162 1167 10.1161/01.ATV.0000021150.63480. CD 12117732
45. Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. King DE, Egan BM, Woolson RF, Mainous A III, Al-Solaiman Y, Jesri A, Arch Intern Med 2007 167 502 506 10.1001/archinte.167.5.502 17353499
46. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, Circulation 2009 120 1640 1645 10.1161/CIRCULATIONAHA.109.192644 19805654
47. Mediterranean diet and the metabolic syndrome. Esposito K, Ciotola M, Giugliano D, Mol Nutr Food Res 2007 51 1268 1274 17879992
48. Prevalence of cardiovascular risk factors and the metabolic syndrome in middle-aged men and women in Gothenburg, Sweden. Welin L, Adlerberth A, Caidahl K, Eriksson H, Hansson PO, Johansson S, Rosengren A, Svärdsudd K, Welin C, Wilhelmsen L, BMC Public Health 2008 8 403 10.1186/1471-2458-8-403 19063738
49. Comparison of apolipoprotein-B/apolipoprotein-A1 in subjects with versus without the metabolic syndrome. Sierra-Johnson J, Somers VK, Kuniyoshi FHS, Garza CA, Isley WL, Gami AS, Lopez-Jimenez F, Am J Cardiol 2006 98 1369 1373 10.1016/j.amjcard.2006.06.029 17134631
50. Beneficial effects of a 5-week low-glycaemic index regimen on weight control and cardiovascular risk factors in overweight non-diabetic subjects. de Rougemont A, Normand S, Nazare JA, Skilton MR, Sothier M, Vinoy S, Laville M, Br J Nutr 2007 98 1288 1298 17617942
51. Low-glycemic-index starchy foods in the diabetic diet. Jenkins DJ, Wolever TM, Buckley G, Lam KY, Giudici S, Kalmusky J, Jenkins AL, Patten RL, Bird J, et al. Am J Clin Nutr 1988 48 248 254 3407604
52. Antiglycative and neuroprotective activity of colon-derived polyphenol catabolites. Verzelloni E, Pellacani C, Tagliazucchi D, Tagliaferri S, Calani L, Costa LG, Brighenti F, Borges G, Crozier A, Conte A, Del Rio D, Mol Nutr Food Res 2011 55 Suppl 1 35 S43 21240902
53. The metabolic syndrome. Eckel RH, Grundy SM, Zimmet PZ, Lancet 2005 365 1415 1428 10.1016/S0140-6736(05)66378-7 15836891
54. C reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. Ridker PM, Hennekens CH, Buring JE, Rifai N, N Engl J Med 2000 342 836 843 10.1056/NEJM200003233421202 10733371
55. A diet high in fatty fish, bilberries and wholegrain products improves markers of endothelial function and inflammation in individuals with impaired glucose metabolism in a randomized controlled trial: The Sysdimet study. de Mello VDF, Schwab U, Kolemainen M, Koenig W, Siloaho M, Poutanen K, Mykkänen H, Uusitupa M, Diabetologia 2011 54 2755 2767 10.1007/s00125-011- 2285-3 21870174
56. Does fish-oil lower blood pressure? A metanalysis of controlled trials. Morris MC, Sacks F, Rosner B, Circulation 1993 88 523 533 8339414
57. Benazepril plus Amlodipine or Hydrochlorothiazide for hypertension in high-risk patients. Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ, N Engl J Med 2008 359 2417 2428 10.1056/NEJMoa0806182 19052124
58. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Estruch R, Martínez-González MA, Corella D, Salas-Salvadá J, Ruiz-Gutiérrez V, Covas MI, Fiol M, Gámez-Gracia E, Lápez-Sabater MC, Vinyoles E, Arás F, Conde M, Lahoz C, Lapetra J, Sáez G, Ros E, the PREDIMED Study investigators, Ann Intern Med 2006 145 1 11 16818923
59. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG, Karanja N, Lin PH, DASH-Sodium Collaborative Research Group, N Engl J Med 2001 344 3 10 10.1056/NEJM200101043440101 11136953
60. Effect of increased consumption of whole-grain foods on blood pressure and other cardiovascular risk markers in healthy middle-aged persons: a randomized controlled trial. Tighe P, Duthie G, Vaughan N, Brittenden J, Simpson WG, Duthie S, Mutch W, Wahle K, Horgan G, Thies F, Am J Clin Nutr 2010 92 733 740 10.3945/ajcn.2010.29417 20685951
61. Effectiveness of a low-fat vegetarian diet in altering serum lipids in healthy premenopausal women. Barnard ND, Scialli AR, Bertron P, Hurlock D, Edmonds K, Talev L, Am J Cardiol 2000 85 969 972 10.1016/S0002-9149(99)00911-X 10760336
62. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F, Diabetes Care 2005 28 2823 2831 10.2337/diacare.28.12.2823 16306540
63. Principles and practice of nonpharmacological interventions to reduce cardiometabolic risk. Dagogo-Jack S, Egbuonu N, Edeoga C, Med Princ Pract 2010 19 167 175 10.1159/000285280 20357497
64. Cholesterol in women at high cardiovascular risk is less successfully treated than in corresponding men. The Skaraborg Hypertension and Diabetes Project. Mehner A, Lindblad U, Råstam L, Boström KB, Eur J Clin Pharmacol 2008 64 815 820 10.1007/s00228-008-0482-x 18389228
65. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2. Santos RD, Waters DD, Tarasenko L, Messig M, Jukema JW, Ferrières J, Verdejo J, Chiang CW, L-TAP 2 Investigators, Am Heart J 2009 158 860 866 10.1016/j.ahj.2009.08.009 19853709